Diabetic Neuropathy Collection: Introduction to Diabetic Neuropathy.

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders

ISSN: 1869-6953

Titre abrégé: Diabetes Ther

Pays: United States

ID NLM: 101539025

Informations de publication

Date de publication:
Apr 2020

Historique:

received: 21 01 2020

pubmed: 19 2 2020

medline: 19 2 2020

entrez: 19 2 2020

Statut: ppublish

Résumé

Introduction to Diabetic Neuropathy podcast recording (MP4 55526 kb).

Identifiants

DOI: 10.1007/s13300-020-00773-6 PMID: 32067217 PMC: PMC7136365

pubmed: 32067217

doi: 10.1007/s13300-020-00773-6

pii: 10.1007/s13300-020-00773-6

pmc: PMC7136365

doi:

Types de publication

Editorial

Langues

eng

Pagination

755-760

Références

Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–4.

doi: 10.1007/BF00400697

Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828–49.

doi: 10.1016/j.clinthera.2018.04.001

Lu B, Yang Z, Wang M, et al. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract. 2010;88(3):289–94.

doi: 10.1016/j.diabres.2010.02.002

Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543.

pmcid: 4048127

Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep. 2014;14(9):528.

doi: 10.1007/s11892-014-0528-7

Gæde P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91.

doi: 10.1056/NEJMoa0706245

Callaghan BC, Gao L, Li Y, et al. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol. 2018;5(4):397–405.

doi: 10.1002/acn3.531

Spallone V, Morganti R, D’Amato C, et al. Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function. Eur J Pain. 2011;15(2):153–60.

doi: 10.1016/j.ejpain.2010.06.011

Pavy FW. Introductory address to the discussion on the clinical aspect of glycosuria. Lancet. 1885;126(3249):1033–5.

doi: 10.1016/S0140-6736(02)29099-6

Koh K, Hamada A, Hamada Y, et al. Possible involvement of activated locus coeruleus–noradrenergic neurons in pain-related sleep disorders. Neurosci Lett. 2015;589:200–6.

doi: 10.1016/j.neulet.2014.12.002

Taylor BK, Westlund KN. The noradrenergic locus coeruleus as a chronic pain generator. J Neurosci Res. 2017;95(6):1336–46.

doi: 10.1002/jnr.23956

Gilron I. Impact of chronobiology on neuropathic pain treatment. Pain Manag. 2016;6(3):241–7.

doi: 10.2217/pmt-2015-0007

Odrcich M, Bailey JM, Cahill CM, Gilron I. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain. 2006;120(1–2):207–12.

doi: 10.1016/j.pain.2005.10.007

Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30(4):374–85.

doi: 10.1016/j.jpainsymman.2005.04.009

Atkin SL, Brown PM. Treatment of diabetic gustatory sweating with topical glycopyrrolate cream. Diabet Med. 1996;13(5):493–4.

doi: 10.1002/(SICI)1096-9136(199605)13:5<493::AID-DIA62>3.0.CO;2-Q

NICE. Hyperhidrosis: oxybutynin. Evidence summary [ES10]. 2017.

Jun JE, Lee S-E, Choi MS, Park SW, Hwang Y-C, Kim JH. Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2019;18(1):29.

doi: 10.1186/s12933-019-0830-4

Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639–53.

doi: 10.1002/dmrr.1239

Costa J, Moreira A, Moreira P, Delgado L, Silva D. Effects of weight changes in the autonomic nervous system: a systematic review and meta-analysis. Clin Nutr. 2019;38(1):110–26.

doi: 10.1016/j.clnu.2018.01.006

NICE. Neuropathic pain in adults: pharmacological management in non-specialist settings. NICE Clinical Guidence [CG173]. 2013.

Boulton AJM. The diabetic foot. Medicine. 2010;38(12):644–8.

doi: 10.1016/j.mpmed.2010.08.011